Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 455-88-9 | MDL No. : | MFCD00007284 |
Formula : | C7H6FNO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | XUCYJGMIICONES-UHFFFAOYSA-N |
M.W : | 155.13 | Pubchem ID : | 68001 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.14 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 40.19 |
TPSA : | 45.82 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.25 cm/s |
Log Po/w (iLOGP) : | 1.63 |
Log Po/w (XLOGP3) : | 2.81 |
Log Po/w (WLOGP) : | 2.46 |
Log Po/w (MLOGP) : | 2.44 |
Log Po/w (SILICOS-IT) : | 0.54 |
Consensus Log Po/w : | 1.98 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.91 |
Solubility : | 0.191 mg/ml ; 0.00123 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.43 |
Solubility : | 0.0577 mg/ml ; 0.000372 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.43 |
Solubility : | 0.576 mg/ml ; 0.00372 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.6 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302+H312+H332-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90% | With silver fluoride In toluene at 150℃; for 12 h; Sealed tube | To an oven-dried resealable tube equipped with a stir bar was added aryl halide as depicted in FIG. 20 (0.12 mmol), BrettPhos (6.4 mg, 0.012 mmol, 10 mol percent), (COD)Pd(CH2TMS)2 (2.3 mg, 0.006 mmol, 5 mol percent), AgF (23 mg, 0.18 mmol) and toluene (2 mL). The tube was then sealed with a screw-cap and taken out of the glove box, wrapped in aluminum foil and placed into a preheated oil bath at the indicated temperature with adequate stirring. After 12, the tube was removed from the oil bath and allowed to cool to room temperature. 4-Fluorotoluene (13.2 μL, 0.12 mmol, 1 equiv) and dodecane (27.3 μL, 0.12 mmol, 1 equiv) were added as standards. The reaction mixture was filtered through a glass filter and a plug of Celite.(R). to remove all solids. Then, it was analyzed by 19F NMR (282 MHz) for yield and GC for conversion. |
[ 1736-85-2 ]
2-Fluoro-1,3-dimethyl-5-nitrobenzene
Similarity: 0.96
[ 1736-87-4 ]
2,3-Dimethyl-4-fluoronitrobenzene
Similarity: 0.93
[ 170572-48-2 ]
1,3-Difluoro-2-methyl-5-nitrobenzene
Similarity: 0.93
[ 437-86-5 ]
2-Fluoro-1-methyl-3-nitrobenzene
Similarity: 0.91
[ 1736-85-2 ]
2-Fluoro-1,3-dimethyl-5-nitrobenzene
Similarity: 0.96
[ 1736-87-4 ]
2,3-Dimethyl-4-fluoronitrobenzene
Similarity: 0.93
[ 170572-48-2 ]
1,3-Difluoro-2-methyl-5-nitrobenzene
Similarity: 0.93
[ 437-86-5 ]
2-Fluoro-1-methyl-3-nitrobenzene
Similarity: 0.91
[ 1736-85-2 ]
2-Fluoro-1,3-dimethyl-5-nitrobenzene
Similarity: 0.96
[ 1736-87-4 ]
2,3-Dimethyl-4-fluoronitrobenzene
Similarity: 0.93
[ 170572-48-2 ]
1,3-Difluoro-2-methyl-5-nitrobenzene
Similarity: 0.93
[ 437-86-5 ]
2-Fluoro-1-methyl-3-nitrobenzene
Similarity: 0.91